A carregar...
Deferasirox: appraisal of safety and efficacy in long-term therapy
Deferasirox is a once-daily, oral iron chelator that is widely used in the management of patients with transfusional hemosiderosis. Several Phase II trials along with their respective extension studies as well as a Phase III trial have established the efficacy and safety of this novel agent in trans...
Na minha lista:
Main Authors: | , |
---|---|
Formato: | Artigo |
Idioma: | Inglês |
Publicado em: |
Dove Medical Press
2013
|
Assuntos: | |
Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3743529/ https://ncbi.nlm.nih.gov/pubmed/23966805 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/JBM.S35478 |
Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|